抗菌药物敏感性试验:耐药时代临床医生的更新版入门指南
本文由感染病药师学会发布,系统介绍抗菌药物敏感性试验(AST)的常用方法(肉汤微量稀释、琼脂稀释、纸片扩散)、商业化自动平台与快速诊断进展,以及FDA与CLSI等机构在折点制定中的角色。文章强调新耐药机制与新药给AST方法及判读带来的挑战,呼吁临床与实验室协作以优化抗菌药物使用和抗菌药物管理。
要点
- AST是优化感染病患者治疗、监测耐药趋势和支撑公共卫生的关键实验室功能。
- 常用AST方法包括肉汤微量稀释、琼脂稀释和纸片扩散,自动平台与快速诊断提升了检测速度与临床适用性。
- 新耐药机制与新药出现要求持续更新AST方法和折点,临床医生应与实验室协作优化判读。
核心结论
- AST对优化感染病治疗、监测耐药趋势和支撑公共卫生至关重要。
- 应对AST挑战需持续开发新技术并促进临床与实验室协作,以优化抗菌药物使用和对抗耐药负担。
研究设计与样本
- 本文为感染病药师学会发布的更新版入门指南,阐述AST原则、实施与优化。
- 文中述及AST方法包括肉汤微量稀释、琼脂稀释和纸片扩散,并提及商业化自动平台与快速诊断技术。
主要发现
- 商业化自动药敏平台和快速诊断技术的发展提升了AST的速度、稳健性和临床应用。
- 新耐药机制出现、新抗菌药物开发及新数据产生,要求对既有方法和折点进行更新与修订。
关键数值与推荐
- 参与AST及折点制定与修订的机构包括美国食品药品监督管理局(FDA)和临床与实验室标准协会(CLSI)。
临床怎么用
- 临床医生应理解AST方法与判读原则,与实验室协作以优化抗菌药物使用和抗菌药物管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial susceptibility testing (AST) is a critical function of the clinical microbiology laboratory and is essential for optimizing care of patients with infectious diseases, monitoring antimicrobial resistance (AMR) trends, and informing public health initiatives. Several methods are available for performing AST including broth microdilution, agar dilution, and disk diffusion. Technological advances such as the development of commercial automated susceptibility testing platforms and the advent of rapid diagnostic tests have improved the rapidity, robustness, and clinical application of AST. Numerous accrediting and regulatory agencies are involved in the process of AST and setting and revising breakpoints, including the U.S. Food and Drug Administration and the Clinical and Laboratory Standards Institute. Challenges to optimizing AST include the emergence of new resistance mechanisms, the development of new antimicrobial agents, and generation of new data requiring updates and revisions to established methods and breakpoints. Together, the challenges in AST methods and their interpretation create important opportunities for well-informed clinicians to improve patient outcomes and provide value to antimicrobial stewardship programs, especially in the setting of rapidly changing and increasing AMR. Addressing AST challenges will involve continued development of new technologies along with collaboration between clinicians and the laboratory to facilitate optimal antimicrobial use, combat the increasing burden of AMR, and inform the development of novel antimicrobials. This updated primer serves to reinforce important principles of AST, and to provide guidance on their implementation and optimization.
引用
- Wenzler E, Maximos M, Asempa TE, et al. Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2023. PMID: 36825480. doi:10.1002/phar.2781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。